Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-05-04Clinical Trial Update: Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors [Phase 1]
Phase 1 dosimetry study of I-131-CLR1404 in patients with relapsed or refractory advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2010-05-03Clinical Trial Update: A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together [Phase 1]
Pfizer-sponsored Phase 1 trial completed to identify the best dosing combination of sunitinib (SU011248) and capecitabine in patients with s…
-
CLINICAL_TRIALS trial_result · 2010-04-27Clinical Trial Update: Safety Study of TAK-593 Given Orally in Subjects With Nonhematologic Advanced Cancer [Phase 1]
Phase 1 safety study evaluating oral TAK-593 in adults with nonhematologic advanced solid tumors; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-27Clinical Trial Update: A Research Study to Evaluate the Safety of R306465, a Drug in Development for Cancer and to Study the Absorption, Break Down and Elimination in Patients With Advanced Solid Malignancies. [Phase 1]
Phase 1 study evaluating the safety, absorption, breakdown and elimination of R306465 in patients with advanced solid tumors; the trial has …
-
CLINICAL_TRIALS trial_result · 2010-04-26Clinical Trial Update: A Safety and Dose-finding Study of JNJ-26483327, a Drug in Development for Cancer, for Patients With Advanced and/or Refractory Solid Malignancies. [Phase 1]
Phase 1 safety and dose-finding study of JNJ-26483327 in patients with advanced solid malignancies has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-02) [Phase 1]
A Phase I study evaluating the safety and tolerability of EZN-2208 in patients with lymphoma or advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-05Clinical Trial Update: A Study to Document Long-Term Safety and Continued Benefit of Irinotecan and Carboplatin or Irinotecan in Subjects With Refractory Solid Tumors (Rollover Study -001, -002) [Phase 1, Phase 2]
This trial update reports a rollover Phase 1/2 study evaluating long-term safety and continued benefit of irinotecan with or without carbopl…
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: SU5416 and Paclitaxel in Treating Patients With Advanced Cancer [Phase 1]
Phase 1 trial update reporting on the combination of SU5416 with paclitaxel in adults with advanced solid tumors. The study has completed en…
-
CLINICAL_TRIALS trial_result · 2009-10-09Clinical Trial Update: A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01) [Phase 1]
A Phase I study evaluating the safety and tolerability of intravenous EZN-2208 in patients with advanced solid tumors or lymphoma has comple…
-
CLINICAL_TRIALS trial_result · 2009-08-26Clinical Trial Update: ARQ 197 in Subjects With Metastatic Solid Tumors [Phase 1]
A Phase 1 trial update for ARQ 197 (tivantinib) in patients with metastatic solid tumors; the study has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-20Clinical Trial Update: Open Label, Dose Escalation Phase I Study of AZD2281 [Phase 1]
This document summarizes an open-label, dose-escalation Phase I trial of AZD2281 (olaparib) in patients with advanced solid tumors, focusing…
-
CLINICAL_TRIALS trial_result · 2009-08-14Clinical Trial Update: Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction [Phase 1]
Pfizer-sponsored Phase 1 trial of irinotecan in patients with refractory solid tumors and liver dysfunction has completed, providing safety …
-
CLINICAL_TRIALS trial_result · 2009-08-11Clinical Trial Update: Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors [Phase 1]
Phase 1 study update of cetuximab (Erbitux) in pediatric patients with refractory solid tumors; the trial completed and results were posted …
-
CLINICAL_TRIALS trial_result · 2009-08-10Clinical Trial Update: Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 dose-escalation study of CX-3543 in patients with advanced solid tumors or lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-10Clinical Trial Update: Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
A Phase 1 dose-escalation study of Quarfloxin in patients with advanced solid tumors or lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-06-03Clinical Trial Update: This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Solid Tumor [Phase 1]
Phase 1 study evaluating Gimatecan in adults with solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-30Clinical Trial Update: Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy [Phase 4]
Phase 4 study evaluating rasburicase for treatment or prevention of hyperuricemia associated with tumor lysis syndrome in patients with rela…
-
CLINICAL_TRIALS trial_result · 2009-03-09Clinical Trial Update: A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid Tumors [Phase 1]
This is an update on a Phase 1 safety trial to determine the maximum tolerated dose of elesclomol sodium in patients with metastatic solid t…
-
CLINICAL_TRIALS trial_result · 2009-02-24Clinical Trial Update: CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial of CT-322 in patients with advanced solid tumors and non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2009-01-28Clinical Trial Update: A Pharmacokinetic Study of Oral Cyclophosphamide and Topotecan in Children With Recurrent Solid Tumors [Phase 2]
Phase 2 pharmacokinetic study in children with recurrent solid tumors evaluating oral cyclophosphamide and topotecan.
-
CLINICAL_TRIALS trial_result · 2008-12-04Clinical Trial Update: STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors [Phase 1]
Phase 1 clinical trial update for STA-5312 administered on alternate weekdays every two weeks in patients with hematologic malignancies and …
-
CLINICAL_TRIALS trial_result · 2008-11-11Clinical Trial Update: Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer [Phase 1]
Phase 1 study of SU011248 in combination with docetaxel in patients with advanced solid tumors and non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2008-10-27Clinical Trial Update: Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma [Phase 1]
Phase 1 study of L-NDDP (Aroplatin) in patients with advanced solid malignancies or B-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2008-10-16Clinical Trial Update: SB-743921 In Patients With Solid Tumors [Phase 1]
This document reports the completion of a Phase 1 study of SB-743921 in patients with solid tumors.
-
CLINICAL_TRIALS trial_result · 2008-10-13Clinical Trial Update: Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas [Phase 1]
A Phase 1 dose-escalation study of SB-485232 given intravenously every 28 days in adults with solid tumors or lymphomas has completed.